Primary cultured human breast epithelial cells up-regulate protein disulfide isomerase in response to zeranol

Anticancer Research

Volumn 27, Issue 1 A, 2007, Pages 407-410

  Updike, Michael Scott ^a   Sawdy, Joseph C ^a   Wang, Li Shu ^a   Liu, Suling ^d   Huang, Yi Wen ^a   Ye, Weiping ^a   Farrar, William B ^b,c   Lin, Young C ^a,b   Wick, Macdonald ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

Breast cancer; Protein disulfide isomerase; Proteomics; Zeranol

Indexed keywords

PROTEIN DISULFIDE ISOMERASE; ZERANOL;

AMINO ACID SEQUENCE; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; BREAST; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EPITHELIAL CELLS; ESTROGENS, NON-STEROIDAL; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN DISULFIDE-ISOMERASE; UP-REGULATION; ZERANOL;

EID: 33847686899     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Eifel P, Axelson JA, Costa J, Crowley J, Curran WJ Jr, Deschler A, Fulton S, Hendricks CB, Kemeny M, Kornblith AB, Louis TA, Markman M, Mayer R and Roter D: National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst 93: 979-989, 2001.
2. Howe HL, Wingo PA, Thun MJ, Ries LA, Rosenberg HM, Feigal EG and Edwards BK: Annual report to the nation on the stauts of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 93: 824-842, 2001.
3. Chodosh LA, D'Cruz CM, Gardner HP, Ha SI, Marquis ST, Rajan JV, Stairs DB, Wang JY and Wang M: Mammary gland development, reproductive history, and breast cancer risk. Cancer Res 59: 1765-1771s, 1999.
4. Harris RE, Namboodiri KK and Wynder EL: Breast cancer risk: effect of estrogen replacement therapy and body mass. J Natl Cancer Inst 84: 1575-1582, 1992.
5. Huang Z, Hankinson SE, Colditz GA, Stampfer MJ, Hunter DJ, Manson JE, Hennekens CH, Rosner B, Speizer FE and Willet WC: Dual effects of weight and weight gain on breast cancer risk. JAMA 278: 1448-1449, 1997.
6. Ross RK, Paganini-Hill A, Wan PC and Pike MC: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst 92: 328-332, 2000.
7. Fisher BJ, Perera FE, Cooke AL, Opeitum A and Stitt L: Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant tamoxifen alone: patterns of recurrence. Int J Radiat Oncol Biol Phys 42: 117-123, 1998.
8. Elenbaas B and Weinberg RA: Heterotypic singalling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res 264: 169-184, 2001.
9. Krtolica A, Parrinello S, Lockett S, Desprez PY and Campisi J: Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci USA 98: 12072-12077, 2001.
10. Mirocha CJ, Pathre SV, Schauerhamer B and Christensen CM: Natural occurrence of Fusarium toxins in feedstuff. Appl Environ Microbiol 32: 553-556, 1976.
11. Diekman MA and Green ML: Mycotoxins and reproduction in domestic livestock. J Anim Sci 70: 1615-1627, 1992.
12. Haseman JK, Crawford DD, Huff JE, Boorman GA and McConnell EE: Results from 86 two-year carcinogenicity studies conducted by the National Toxicology Program. J Toxicol Environ Health 14: 621-639, 1984.
13. Katzenellenbogen BS, Iwamoto HS, Heiman DF, Lan NC and Katzenellenbogen JA: Stilbesterols and stilbestrol derivatives: estrogenic potency and temporal relationships between estrogen receptor binding and uterine growth. Mol Cell Endocrinol 10: 103-113, 1979.
14. Moran, C, Quirke JF, Prendeville DJ, Bourke S and Roche JF: The effect of estradiol, treenbalone acetate, or zeranol on growth rate, mammary development, carcass traits, and plasma estradiol concentrations of beef heifers. J Anim Sci 69: 4249-4258, 1991.
15. Sheffield LG and Welsch CW: Zeranol (beta-resorcyclic acid lactone), a common redisous component of natural foodstuffs, stimulates developmental growth of the mouse mammary gland. Cancer Lett 28: 77-83, 1985.
16. Liu S and Lin YC: Transformation of MCF-10A human breast epithelial cells by zeranol and estradiol-17beta. Breast J 10: 514-521, 2004.
17. Liu S, Sugimoto Y, Sorio C, Tecchio C and Lin YC: Function analysis of estrogenically regulated protein tyrosine phosphatase gamma (PTPgamma) in human breast cancer cell line MCF-7. Oncogene 23: 1256-1262, 2004.
18. Welshons WV, Rottinghaus GE, Nonneman DJ, Dolan-Timpe M and Ross PF: A sensitive bioassay for detection of dietary estrogens in animal feeds. J Vet Diagn Invest 2: 268-273, 1990.
19. Leffers H, Naesby M, Vendelbo B, Skakkebaek NE and Jorgensen M: Oestrogenic potencies of Zeranol, oestradiol, diethylstilboestrol, Bisphenol-A and genistein: implications for exposure assessment of potential endocrine disrupters. Hum Reprod 16: 1037-1045, 2001.
20. Liu S, Sugimoto Y, Kulp SK, Jiang J, Chang HL, Park KY, Kashida Y and Lin YC: Estrogenic down-regulation of protein tyrosine phosphatase gamma (PTP gamma) in human breast is associated with estrogen receptor alpha. Anticancer Res 22: 3917-3923, 2002.
21. Liu S, Kulp SK, Sugimoto Y, Jiang J, Chang HL and Lin YC: Involvement of breast epithelial-stromal interactions in the regulation of protein tyrosine phosphatase-gamma (PTPgamma) mRNA expression by estrogenically active agents. Breast Cancer Res Treat 71: 21-35, 2002.
22. Coe JE, Ishak KG, Ward JM and Ross MJ: Tamoxifen prevents induction of hepatic neoplasia by zeranol, an estrogenic food contaminant. Proc Natl Acad Sci USA 89: 1085-1089, 1992.
23. Görg A, Obermaier C, Boguth G, Harder A, Scheibe B, Wildgruber R and Weiss W: The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21: 1037-1053, 2000.
24. Shevchenko A, Wilm M, Jensen ON, Podtelejnikov, AV, Neubauer G, Schevchenko A, Mortensen P and Mann M: A strategy for identifying gel-separated proteins in sequence databases by MS alone. Biochem Soc Trans 24: 893-896, 1996.
25. Claudio JO, Masih-Khan E, Tang H, Goncalves J, Voralia M, Li ZH, Nadeem V, Cukerman E, Francisco-Pabalan O, Liew CC, Woodgett JR and Stewart AK: A molecular compendium of genes expressed in multiple myeloma. Blood 100: 2175-2186, 2002.
26. Shin BK, Wang H, Yim AM, Le Naour F, Brichory F, Jang JH, Zhao R, Puravs E, Tra J, Michael CW, Misek DE and Hanash SM: Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J Biol Chem 278: 7607-7616, 2003.
27. Voss T, Ahorn H, Haberl P, Dohner H and Wilgenbus K: Correlation of clinical data with proteomics profiles in 24 patients with B-cell chronic lymphocytic leukemia. Int J Cancer 91: 180-186, 2001.